Offer new treatments only as part of post-market trials until data on meaningful outcomes are available, says Ben Goldacre to BMJ

Watch the video from the BMJ channel below:

Posted by Author on
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)